SEARCH

SEARCH BY CITATION

References

  • 1
    Berger R, Moertl D, Peter S, et al. N-terminal pro-B-type natriuretic peptide-guidedintensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol. 2010;55:645653.
  • 2
    Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884888.
  • 3
    Dickstein K, Cohen-Solal A, Filippatos G, for Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):23882442. Epub 2008 Sep 17.
  • 4
    Lewin J, Ledwidge M, O’Loughlin C, et al. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail. 2005;7:953957.
  • 5
    Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalisation for heart failure. Circulation. 2007;116:15491554.
  • 6
    Chakko S, Wosko D, Martinez H, et al. Clinical, radiographic and haemodynamic correlations in chronic congestive heart failure; conflicting results may lead to inappropriate care. Am J Med. 1991;90:353359.
  • 7
    Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824839.
  • 8
    Maisel AS, McCord J, Nowak RM, for the Breathing Not Properly Multinational Study Investigators. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol. 2003;41(11):20102017.
  • 9
    O’Hanlon R, O’Shea P, Ledwidge M, et al. The biologic variability of Btype natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail. 2007;13:5055.
  • 10
    Nagueh SF, Middleton KJ, Kopelen HJ, et al. Doppler-tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:15271533.
  • 11
    Mullens W, Borowski AG, Curtin RC, et al. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation. 2009;119:6267.
  • 12
    Sergy G, Bussolotto M, Perini P, et al. Accuracy of bioelectrical impedance analysis in estimation of extracellular space in healthy subjects and in fluid retention states. Ann Nutr Metab. 1994;38:158165.
  • 13
    Piccoli A, Rossi B, Pillon L, et al. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int. 1994;46:534539.
  • 14
    Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure; correlation with fluid status and feasibility and early warning preceding hospitalisation. Circulation. 2005;112:841848.
  • 15
    Abraham WT. Intrathoracic impedance monitoring for early detection of impending heart failure decompensation. Congest Heart Fail. 2007;13:113115.
  • 16
    Packer M, Abraham WT, Mehra MR, et al. Utility of impedance cardiography for the identification of short term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006;47:22452252.
  • 17
    Kataoka H. A new monitoring method for the estimation of body fluid status by digital weight scale incorporating bioelectrical impedance analyser in definite heart failure patients. J Card Fail. 2009;15:410418.
  • 18
    Parrinello G, Paterna S, Di Pasquale P, et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnoea due to congestive heart failure. J Card Fail. 2008;14:676686.
  • 19
    Paterna S, Di Pasqulae P, Parrinello G, et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high dose furosemide and hypertonic saline solution versus high dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol. 2005;45:19972003.